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ADP-ribosylation is a post-translational modification that
can alter the physical and chemical properties of target proteins
and that controls many important cellular processes. Macrodo-
mains are evolutionarily conserved structural domains that bind
ADP-ribose derivatives and are found in proteins with diverse
cellular functions. Some proteins from themacrodomain family
can hydrolyzeADP-ribosylated substrates and therefore reverse
this post-translationalmodification. Bacteria and Streptomyces,
in particular, are known to utilize protein ADP-ribosylation, yet
very little is known about their enzymes that synthesize and
remove this modification. We have determined the crystal
structure and characterized, both biochemically and function-
ally, themacrodomainprotein SCO6735 from Streptomyces coe-
licolor. This protein is a member of an uncharacterized subfam-
ily of macrodomain proteins. Its crystal structure revealed a
highly conservedmacrodomain fold.We showed that SCO6735
possesses the ability to hydrolyze PARP-dependent protein
ADP-ribosylation. Furthermore, we showed that expression of
this protein is induced upon DNA damage and that deletion of
this protein in S. coelicolor increases antibiotic production. Our
results provide the first insights into the molecular basis of its
action and impact on Streptomycesmetabolism.
Protein ADP-ribosylation is a reversible post-translational
modification in which an ADP-ribose moiety from NAD is
transferred to a target protein. The covalent attachment of one
ADP-ribose leads to mono-ADP-ribosylation, whereas the
transfer of additional ADP-ribose molecules through O-glyco-
sidic ribose-ribose bonds results in the synthesis of poly-ADP-
ribose (PAR)4 polymers. The families that generate protein
ADP-ribosylation, poly-ADP-ribosepolymerases (PARPs),mono-
ADP-ribosyltransferases, and certain sirtuins, in eukaryotes reg-
ulate a variety of cellular processes, such as DNA repair, tran-
scription, regulation of centromere function, telomere length
and aging, protein degradation, apoptosis, and necrosis (1–5).
Poly-ADP-ribose glycohydrolase (PARG) is one of the proteins
capable of removing ADP-ribosylation. PARG specifically
cleaves PAR chains at O-glycosidic ribose-ribose bonds releas-
ingADP-ribosemonomers or PARoligomers, but it is unable to
cleave the chemical bond between the proximal ADP-ribose
unit and themodified proteins (6). Recent studies have demon-
strated that a family ofmacrodomain proteins (MacroD1,Mac-
roD2, and TARG1) can revert terminal, protein-proximal glu-
tamate-linked mono-ADP-ribosylation (1, 7–9). TARG1,
MacroD1/2, and PARG represent different subgroups within
the macrodomain protein family (10). Macrodomains are
ancient folds with high affinity for ADP-ribose binding (11, 12).
These three macrodomain subgroups use the macrodomain
for catalysis but with distinct mechanisms (reviewed in Ref.
1). Furthermore, an evolutionarily distinct protein that can cat-
alyze the removal of the protein-proximal arginine-linked
mono-ADP-ribosylation is a mono-ADP-ribosylhydrolase
(ARH) 1 (13). Importantly, reversal of post-translational mod-
ification has been established as important in many cellular
processes (7, 14, 15).
Although ADP-ribosylating bacterial toxins, which act by
irreversibly modifying crucial host cell proteins, were discov-
ered over 40 years ago (reviewed in Ref. 16), reversible mono-
ADP-ribosylation and its role in signaling in bacteria is gener-
ally not well understood. Physiologically important, non-toxic
mono-ADP-ribosylation has been extensively studied only in
nitrogen-fixing bacteria Rhodospirillum rubrum, where the
enzymes dinitrogenase reductase mono-ADP-ribose transfer-
ase and dinitrogenase reductase-activating glycohydrolase
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(DraG) regulate nitrogen fixation depending on nitrogen avail-
ability and energy status of the cell (17). Being the best charac-
terized, bacterial DraG (homologue of human ARH1 and
ARH3) is a representative of the group of arginine-specific
ADP-ribosylhydrolases whose homologues are distributed
across all three domains of life. Endogenous ADP-ribosylation
has also been reported for some other bacteria, Myxococcus
xanthus (18, 19),Mycobacterium smegmatis (20), Bacillus sub-
tilis (21), and Streptomyces representatives (22–25), but little is
known about its function in bacteria. Genomic evidence indi-
cates that proteins involved in ADP-ribosylation processing are
widespread among bacteria. Although PARP homologues are
found rarely, PARG and other macrodomain protein homo-
logues are found more often, suggesting that protein ADP-ri-
bosylation is more common than previously thought (10). So
far, the most evidence for intracellular endogenous protein
ADP-ribosylation has been found in Streptomyces species.
Streptomyces are soil bacteria well known for their complex life
cycle, which includes morphological differentiation and pro-
duction of secondary metabolites including antibiotics, anti-
cancer drugs and immunosuppressors. In Streptomyces griseus
and Streptomyces coelicolor, just like in other bacteria in which
ADP-ribosylation has been studied, ADP-ribosylation patterns
change with morphological differentiation and are related
to changes in metabolic requirements (24, 26). However,
almost nothing is known about transferases and hydrolases
responsible for the reversible ADP-ribosylation in these
organisms.
Thus far, no proteins have been identified that have the abil-
ity to reverse (hydrolyze) protein ADP-ribosylation in Strepto-
myces and most other bacterial organisms. Here, we analyzed
the S. coelicolor genome and found a number of possible candi-
dates, including homologues of human PARG andMacroD1, as
well as an uncharacterized type of macrodomain protein,
SCO6735. We have focused our research on SCO6735 because
we could show that it encompasses a macrodomain evolution-
arily close to the ALC1 (amplified in liver cancer)/TARG1 (ter-
minal ADP-ribose protein glycohydrolase) macrodomain
group. Here we determine the structure of SCO6735 and show
that this protein hydrolyzes glutamate-linked protein mono-
ADP-ribosylation. Furthermore, we show that depletion of
SCO6735 leads to a significantly increased production of anti-
biotic actinorhodin in S. coelicolor.
Results
Putative ART and ARHs in Streptomyces—Our genomic
analyses and homology searches predict the existence of only
one potential ART in S. coelicolor, SCO5461, which confirms
previous findings (27). SCO5461 is a highly diverged PARP ho-
mologue most similar to pierisins and mosquitocidal toxin and
can modify guanosine and guanine mononucleotides in vitro,
whereas its ability to directly modify proteins and in vivo sub-
strates in general has not been clarified (28). SCO5461 is a
secreted protein and is not found in S. griseus and most other
Streptomyces species; thus it cannot be the major cellular pro-
tein ART in streptomycetes.
On the other hand, our analyses revealed a number of puta-
tive ADP-ribosyl protein hydrolases in S. coelicolor and other
streptomycetes, suggesting a lively ADP-ribosylation metabo-
lism. We identified both DraG-like (SCO0086, SCO1766,
SCO2028, SCO2029, SCO2030, SCO4435, and SCO5809) and
macrodomain containing (SCO0909, SCO6450, and SCO6735)
hydrolases. Two of three macrodomain proteins have pre-
dicted functions. The SCO0909 protein of S. coelicolor is a
bacterial-type PARG, predicted to remove poly-ADP-ribosy-
lation (6); whereas SCO6450 is a macrodomain protein pre-
dicted to remove mono-ADP-ribosylation, it is a homologue
of theMacroD proteins, which are present in representatives
from all three domains of life (10, 12). We focused our
research on the third macrodomain protein, SCO6735.
SCO6735 is a 161-amino acid protein with molecular weight
of 17.4 kDa that belongs to an uncharacterized subgroup of
macrodomain proteins. The orthologues of SCO6735 are
less widely distributed than MacroD orthologues but still
found in several bacterial phyla (Bacteroidetes, Firmicutes,
and Planctomycetes). They are most frequent among
Actinobacteria.
SCO6735 Is aMacrodomain Protein ThatGroups into ALC1/
TARG1 Branch—We performed phylogenetic analysis using
selected bacterial macrodomain proteins and human represen-
tatives of differentmacrodomain groups. Phylogenetic analyses
showed that the SCO6735 groups into the ALC1/TARG1
branch (Fig. 1). ALC1 is a chromatin remodeler that uses its
macrodomain to bindDNAdamage induced poly-ADP-ribosy-
lation (29). TARG1 removes PARP-dependent mono-ADP-ri-
bosylation (7). SCO6735 shares 27% identity and 45% similarity
with the humanALC1macrodomain and 13% identity and 28%
similarity with the TARG1 macrodomain.
Sequence alignment (Fig. 2) revealed conserved residues
shared by SCO6735 and protein BT1257, from Bacteroides
thetaiotaomicron, the most similar bacterial protein with a
known crystal structure (unpublished, PDB code 2FG1). These
two proteins share 48% identity and 62% similarity, and we
assumed that the hypothetical protein BT1257 is likely the
SCO6735 orthologue. It is worth noting that the residues
important for ADP-ribose binding (Lys84) and hydrolytic activ-
ity (Asp125) of human TARG1 are not conserved in SCO6735
and BT1257 proteins.
Biochemical Activity of SCO6735 Protein—We wanted to
assess whether SCO6735 has the ability to hydrolyze protein
ADP-ribosylation, as has been demonstrated for some other
macrodomain family members. First, we sought to determine
whether the only predicted ART in S. coelicolor, SCO5461, can
modify itself in vitro. Using an ADP-ribosyltransferase assay
with [32P]NAD as an ADP-ribose donor and the purified
SCO5461N34, we showed significant automodification activ-
ity.However,mono-ADP-ribosylated SCO5461N34was not a
substrate for SCO6735, because we observed no decrease of the
radioactive signal (Fig. 3A). We performed mass spectrometry
analysis and identified aspartate 161 as a modification site on
the auto-ADP-ribosylated SCO5461N34. Next, we used a
(heterologous) model substrate: mono-ADP-ribosylated
PARP1 E988Q mutant, which is known to be modified mostly
on glutamate residues (7). Using this substrate, we observed
removal of radioactive signal suggesting enzymatic activity of
SCO6735 againstmono-ADP-ribosylated proteinsmodified on
S. coelicolor Macrodomain Protein SCO6735
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glutamate residues (Fig. 3B). SCO6735 hydrolytic activity was
partially abolished by a mutation of glycine 128 in glutamate
(Fig. 3,B andC). To analyze the nucleotide product of SCO6735
activity, we used the automodified GST-PARP10cd as a sub-
strate and assayed the reaction products by thin layer chroma-
tography (Fig. 3D). Our data showed that a major by-product
of hydrolytic reaction is ADP-ribose, as seen for other macrodo-
main hydrolases (12). However, because the catalytic residues
FIGURE1.Maximumlikelihoodphylogenetic tree illustrating the relationshipbetweenselected representativemacrodomains.Humanproteins (Hsap)
and bacterial PARG from Thermomonospora curvata (Tcur) are shown in bold type. S. coelicolor proteins are circled. Remaining macrodomain proteins were
selected from the following bacterial species: B. thetaiotaomicron (Bthe), Deinococcus frigens (Dfri), Deinococcus pimensis (Dpim), D. radiodurans (Drad), E. coli
(Ecol), Herpetosiphon aurantiacus (Haur), Listeria monocytogenes (Lmon), Myxococcus fulvus (Mful), and M. xanthus (Mxan). Sequence accession numbers are
given in parentheses. Bootstrap values ML (60%) are given above the lines, and MCMC values are given (0.6) below the lines. The scale bar indicates the
genetic distance of the branch lengths.
FIGURE 2. Structure-based alignment of selectedmacrodomain protein sequences.Designated secondary structure elements refer to SCO6735. Residues
responsible for binding and hydrolysis of ADP-ribose in human TARG1 (Lys84 and Asp125) are marked with asterisks.
S. coelicolor Macrodomain Protein SCO6735
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found in other macrodomain proteins such as TARG1 are not
conserved in SCO6735 (Fig. 2), we conclude that the catalytic
mechanism should be unique for the SCO6735 macrodomain
subclass.
Structure of SCO6735 Confirms Different Catalytic Residues
Compared with TARG1—To better understand the structure-
function relationship of SCO6735 hydrolytic activity, we deter-
mined a high resolution (1.60Å) crystal structure of this protein
(Fig. 4). The structure of SCO6735 revealed highly conserved
three-layered -- sandwich macrodomain fold with a deep
cleft that, by analogy with other macrodomain proteins, repre-
sents a putative ligand-binding site. A central six-stranded
-sheet contains a mixture of five parallel and one anti-parallel
strand, and it is surrounded by four -helices. Structure align-
ment using PDBeFold (30) revealsmany structural homologues
within the PDB. Those most similar to SCO6735 are the struc-
ture of protein BT1257 from B. thetaiotaomicron (PDB code
2FG1; Z score of 14.4; RMSD 0.77) and the structure of human
TARG1/C6orf130 (PDB code 4J5R; Z score of 9.4; RMSD 2.04)
(7). Structural alignment of these three structures shows a high
degree of similarity among them, with significant differences
only in the loop regions.
The most pronounced difference is observed in the phos-
phate binding loop position. It was previously shown that, as for
example in TARG1/C6orf130 protein, in both apo and com-
plexed structures, the phosphate binding loop has the same
position and encloses substrate within the active site (7). Sur-
prisingly, in SCO6735 this loop is located far away (15 Å)
from the binding cleft (Fig. 4). Two amino acids from this loop,
Gly126 and Cys127, which were not well defined in the electron
density maps, are omitted. B-factors in phosphate binding loop
region are not significantly higher than B-factors of the sur-
rounding amino acids, as also observed for TARG1/C6orf130
and BT1257 apo proteins, indicating similar flexibility of this
loop in all three considered structures.
For TARG1/C6orf130 protein also NMR solution structures
for both apo and ADP-ribose-bound complex are available in
the literature (31). Interestingly, in none of the 20 final NMR
conformers from apo and 20 from the complexed protein phos-
phate binding loop reaches a position so far away from the
binding cleft as in SCO6735 structure. To check that the posi-
tion of the phosphate binding loop in our structure is not a
consequence of crystal packing, we carefully checked all con-
tacts between amino acids composing the phosphate binding
FIGURE 3. Activity of SCO6735 protein. A, activity of SCO6735 on 32P-automodified SCO5461N34 substrate. The arrow indicates the position of
SCO5461N34 protein. B, activity of SCO6735 on automodified PARP1 E988Q protein. Recombinant PARP1 E988Q (0.5 M) was automodified in presence of
[32P]NAD and treated or not with 1M of SCO6735 orwith 1M of SCO6735G128Emutant. Right panel, Coomassie staining of dried gel exposed in left panel.
C, quantification of residual 32P-labeled ADP-ribose on PARP1 E988Q after treatment with buffer, SCO6735 or SCO6735 G128Emutant. The ratio between the
intensity of each autoradiography band and correspondent intensity in Coomassie staining data are themeans S.D. of the values obtained in two indepen-
dent experiments. D, TLC analyzing the by-products of incubation of GST-PARP10cd immobilized on beads with buffer or SCO6735. ADP-ribose marker was
obtained treating recombinant wild type PARP1 with recombinant human PARG enzyme.
FIGURE 4. Three-dimensional structure of SCO6735 (magenta) superim-
posed on a human TARG1/C6orf130 (PDB code 4J5R, green) and bacte-
rial, B. thetaiotaomicron (PDB code 2FG1, blue) proteins. Human protein
is in complex with PARG inhibitor ADP-HPD. ADP-HPD, as well as amino acids
important for ligand binding (Lys84) and catalytic activity (Asp125) and corre-
sponding amino acids in bacterial structures (Gln85 and Ala130 in SCO6735
andGln82 andAla128 in BT1257) are shown in stick representation. Amino acids
that could not be well defined in the electron density maps are omitted and
shown by dashed line.
S. coelicolor Macrodomain Protein SCO6735
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loop and surrounding symmetry equivalent molecules. We
found out that there is only one hydrogen bond (Leu129
N-H . . . O1B Asp156). There are no polar amino acids in the
phosphate binding loop (123RIGCGLAGG133), except for the
first arginine residue, suggesting that it is not very likely that
electrostatic contacts are responsible for phosphate binding
loop configuration. The same is valid for hydrophobic interac-
tions caused by a lack of hydrophobic residues in this loop.
A structural comparison shows that the catalytic residues of
TARG1 (Lys84 and Asp125) are not conserved in SCO6735 and
BT1257 (replaced by Gln and Ala, respectively), additionally
confirming that these proteins utilize different catalytic mech-
anism. Up to now we were not able to obtain the SCO6735
structure with bound ADP-ribose.
SCO6735 Is UV-inducible—To further understand the phys-
iological function of SCO6735, we analyzed its promoter region
to get an insight into the transcriptional regulation of the gene
product. Strikingly, in the intergenic region, upstream of the
SCO6735 gene, we found a highly conserved RecA-NDp type of
promoter. Because this type of promoter precedes numerous
genes involved in the DNA damage response in Actinomyce-
tales (32, 33), it strongly suggested connection of SCO6735
macrodomain protein with DNA damage response in Strepto-
myces. Furthermore, the RecA-NDp promoter is also found
upstream of SCO6735 homologues in several other Streptomy-
ces species (Fig. 5).
We tested whether the SCO6735 gene is inducible by the
SOS response. Regulation of SCO6735 gene expression upon
DNA damage was analyzed using UV light as a DNA-damaging
agent. Using a PCR analysis (Fig. 6A), we observed that expression
of the SCO6735 gene in the S. coelicolor WT strain was notably
increased after UV irradiation. To quantify this observation, we
performedquantitative real timePCRanalysis using a gene for 16S
rRNA as an invariant endogenous control and recA gene as a pos-
itive control. Quantitative real time PCR (Fig. 6B) confirmed that
the expression of the SCO6735 gene was significantly (5-fold)
increased (two-tailed t test,p 0.0337) afterDNAdamage caused
by UV irradiation, thus implicating involvement of the SCO6735
protein in the DNA damage response.
Disruption of the SCO6735 Gene and Mutant Phenotype—
The DNA damage response promoter suggested that SCO6735
proteinmay have aDNA repair function, so we decided to inac-
tivate the gene encoding SCO6735 protein in S. coelicolor and
analyze the phenotypes.We used the REDIRECT gene replace-
ment procedure (34) to replace the SCO6735 gene from the
S. coelicolor WT strain by an apramycin resistance cassette as
described under “Experimental Procedures.” Disruption of
the SCO6735 gene was confirmed by PCR, Southern hybrid-
ization of genomic DNA and qRT-PCR (data not shown).
The deletion mutant used for further analysis was named
S. coelicolor 6735.
To analyze whether the S. coelicolor 6735 strain exhibits
sensitivity to DNA damage, we performed assays with two dif-
ferentmutagens. Spores of S. coelicolorWTand SCO6735 dele-
tionmutantwere irradiatedwithUV light (up to 300 Jm2) and
treated with methyl methanesulfonate (MMS; up to 13 g/l)
as described. Survival rates were determined as shown in Fig. 7.
We did not notice significant differences in the survival rate
between S. coelicolor WT and S. coelicolor 6735 strains after
UV or MMS treatment. The absence of a DNA damage-sensi-
tive phenotype could be a consequence of redundant pathways
that can efficiently repair damage produced by UV-light and
MMS. Alternatively, it is quite possible that SCO6735 is not
directly involved in DNA repair.
To explore other phenotypes, we assessed the growth of
S. coelicolor 6735 on various culture media that might reveal
changes in secondary metabolism. When grown on minimal
medium, S. coelicolor 6735 showed a “blue phenotype,” sug-
FIGURE 5. Alignment of the RecA-NDp promoter sequences ofMycobac-
terium tuberculosis (Mtub) and S. coelicolor (Scoe) recA genes with
SCO6735 and its orthologues in other Streptomyces species. Sliv, S. livi-
dans; Sgri, S. griseus; Save, Streptomyces avermitilis; Sdav, Streptomyces dava-
wensis; Sful, Streptomyces fulvissimus. Putativepromoter sequences areboxed,
and the (potential) transcription start sites are underlined. The numbers indi-
cate the distance to the starts of translation with respect to the shown
sequences. GenBankTM accession numbers for the sequences are given in
parentheses.
FIGURE 6. Expression of SCO6735 gene is up-regulated upon DNA dam-
age. cDNA from untreated (UT) and UV-irradiated (200 J m2) mycelium (UV)
of S. coelicolorwild type strainwasusedas a template for PCR (A) andqRT-PCR
analyses (B). S. coelicolorgenomicDNA (gDNA)was used as a control template
in PCR analysis. The data represent themean values from three independent
experiments. The error bars represent standard error of the mean.
S. coelicolor Macrodomain Protein SCO6735
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gesting accelerated and higher production of antibiotic acti-
norhodin when compared with the wild type strain (Fig. 8). To
confirm that this phenotype is specifically due to disruption of
SCO6735 function, we performed complementation analysis
using ectopically expressed SCO6735. The SCO6735 gene,
togetherwith its RecA-NDppromoter region, was cloned into the
site-specific integrating vector pMS82 and integrated into the
S. coelicolor 6735 strain genome. The complementation strain,
named S. coelicolorC6735, showed reversion of the blue pheno-
type, indicating that the observed phenotype is a consequence of
SCO6735 gene inactivation (Fig. 8).
Quantification of Actinorhodin Production in S. coelicolor
6735Mutant—Because the SCO6735-deficient strain showed
a conditional effect on the production of antibiotic acti-
norhodin, we quantified the level of actinorhodin in S. coeli-
color WT, SCO6735-deficient, and complementation strains.
All strains were grown in liquid minimal medium for 5 days,
and aliquots taken every 24 hwere used to quantify intracellular
and extracellular actinorhodin content. Pooled data for all
days and measurements showed (Fig. 9) that actinorhodin lev-
els in SCO6735-deficient mutant increased over time and were
significantly higher compared with both the WT and comple-
mentation strains. S. coelicolor 6735 produced significantly
more intracellular actinorhodin than both of the reference gen-
otypes, on average 6.5 times more than the wild type and 8.72
times more than complementation strain (one-way ANOVA,
p	 0.0001). Similar results were observed for the extracellular
actinorhodin. The S. coelicolor 6735 strain produced on aver-
age 5.57 and 10.3 times more extracellular actinorhodin than
the wild type and complementation strain, respectively (one-
wayANOVA, p	 0.0001).Wild type and the complementation
strain did not significantly differ in the levels of either intracel-
lular (one-way ANOVA, p 0.9232) or extracellular (one-way
ANOVA, p 0.8636) actinorhodin.
Deregulation of Actinorhodin-related Gene Expression in
S. coelicolor 6735 Mutant—Using qRT-PCR, we analyzed
whether deficiency in SCO6735 protein influences expression
of genes responsible for actinorhodin biosynthesis and regula-
tion. Biosynthesis of the polyketide antibiotic actinorhodin is
determined by20 genes organized in five transcription units
within the act gene cluster (35) dependent on the ActII-ORF4
protein, which binds to sequences in the target promoters (36).
Two genes from the actinorhodin biosynthesis cluster that we
included in our analysis were actinorhodin cluster activator
protein (actII-ORF4) gene SCO5085 and -subunit of acti-
norhodin polyketide -ketoacyl synthase (actI-ORF1) gene
SCO5087. Expression of these genes was analyzed in the S. coe-
licolorWT strain, SCO6735-deficient mutant, and the comple-
mentation strain. The strains were grown in liquid minimal
medium for 5 days, and total RNA was isolated from the sam-
ples taken every 24 h. Our results (Fig. 10) confirmed that
expression of both genes involved in actinorhodin biosynthesis
was significantly increased in SCO6735-deficient strain com-
pared with WT strain (two-tailed t-tests, p  0.0148 and p 
0.0001 for SCO5085 and SCO5087, respectively).Wild type and
the complementation strain did not significantly differ in the
FIGURE 7.UV andMMS sensitivity of the S. coelicolor6735mutant compared with wild type. The data represent the mean values from three indepen-
dent experiments. The error bars represent standard error of the mean.
FIGURE 8. Blue phenotype of S. coelicolor6735mutant in liquid (A) and
on solid (B) minimal medium comparedwith wild type and complemen-
tation strain (C6735) phenotypes.
S. coelicolor Macrodomain Protein SCO6735
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levels of both SCO5085 and SCO5087 gene expression (two-
tailed t-tests, p 0.6974 and p 0.6579, respectively).
Discussion
Very little is known about bacterial reversible ADP-ribosyla-
tion, with the exception of the role in nitrogen fixation in Rho-
dospirillum and Azotobacter species (17). Scattered evidence
suggests that ADP-ribosylation in bacteria is much more com-
mon in regulating important cellular pathways, e.g. develop-
ment and possibly mediating cell-cell contact in M. xanthus
(18, 19), differentiation process in B. subtilis (21), and differen-
tiation and secondary metabolism in Streptomyces (22, 37).
Finally, here we suggest the possible involvement of the de-
ADP-ribosylation process in the control of S. coelicolor antibi-
otic production.However, a direct role of SCO6735 protein and
de-ADP-ribosylation reactions in this process remains to be
experimentally verified. Transferases and hydrolases involved
in ADP-ribosylation processes remain largely uncharacterized
in bacteria. Genomic evidence indicates that only a small num-
ber of bacterial species possess all genes encoding proteins
essential for a functional PARmetabolism, although there is no
evidence that functional PAR metabolism really exists in bac-
teria. These genes were possibly acquired through horizontal
gene transfer (6, 38), and bacteria might have evolved to use
PARG as counteracting factor of the potentially harmful ADP-
ribose/PARpresent in the environment. PARGs are present in a
scattering of bacteria. InDeinococcus radiodurans PARG is one
of the highly induced proteins upon DNA damage caused by
UV light (39). Protein mono-ADP-ribosylation is predictably
more common in bacteria (10), where homologues of MacroD
proteins are the most abundant representatives. Macrodomain
protein YmdB from Escherichia coli seems to be a multifunc-
tional protein that regulates RNase III activity and modulates
bacterial biofilm formation (40).
Current genomic data suggest that ADP-ribosylation should
be prominent in Streptomyces, with one possible ART and
many ARHs. Even though ADP-ribosylation has been noted in
Streptomyces more than 20 years ago, there is still very little
mechanistic understanding of how ADP-ribosylation is regu-
lated in these organisms. So far, only one ADP-ribosyltrans-
ferase has been identified in Streptomyces: SCO5461 protein. In
accordance with structural similarity with two toxic ADP-ribo-
syltransferases, pierisins and mosquitocidal toxin, SCO5461
has been described as aDNA-modifying exotoxin, and its ADP-
ribosylating activity toward N2 amino groups of guanine
nucleosides, as well as mononucleotides, has been shown (28).
Szira´k et al. (37) have shown that disruption of SCO5461 leads
FIGURE 9. The content of intracellular and extracellular actinorhodin in S. coelicolorWT,6735mutant, and complementation strain (C6735) over
5 days of growth inminimal medium. The data represent the mean values from three independent experiments. The error bars represent standard error of
the mean.
FIGURE 10.Quantitative real time PCR analysis of genes involved in the biosynthesis of actinorhodin, SCO5085, and SCO5087 in S. coelicolor6735
mutant, wild type and complementation strain. Samples for RNA isolation were taken during the 5 days of growth inminimal medium. The data represent
the mean values from three independent experiments. The error bars represent standard error of the mean.
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to conditional pleiotropic phenotype characterized bymorpho-
logical differentiation and antibiotic production defects. In
addition, the same authors showed that deficiency in SCO5461
leads to a minor effect in protein ADP-ribosylation patterns;
however, the question remained whether the effect was direct
(37). Here we confirmed auto mono-ADP-ribosylating activity
of the SCO5461 protein in vitro, but its specific protein trans
targets are yet to be discovered. Several identified ADP-ribosy-
lated proteins in S. coelicolor suggested a connection between
protein ADP-ribosylation and the regulation of metabolic
requirements of the cells (25, 41). SCO5461 is not conserved
across the Streptomyces species (including S. griseus), suggest-
ing that the major protein ADP-ribosyltransferases in Strepto-
myces are yet to be uncovered.
Surprisingly, there is evidence of a much larger number of
potential ADP-ribose protein hydrolases in S. coelicolor. Seven
of them are uncharacterized DraG homologues (SCO0086,
SCO1766, SCO2028, SCO2029, SCO2030, SCO4435,
and SCO5809), whereas three are macrodomain proteins
(SCO0909, SCO6450, and SCO6735), representing three dif-
ferent groups of macrodomain superfamily. Although in
eukaryotes macrodomains exist as compositions with other
domains forming functionally complex proteins like ALC1,
PARP9, andmacroH2A1 (29, 42, 43), macrodomain proteins in
bacteria are usually stand-alone proteins. Our preliminary
results indicate that SCO6450, just like its human homologue
MacroD1, indeed possesses enzymatic activity capable of
removing ADP-ribose from mono-ADP-ribosylated protein.
The SCO0909 protein is a bacterial-type PARG. Bacterial-type
PARGs are much shorter than the proteins in human and
higher eukaryotes and encompass only the PARG catalytic
domain but are highly active and specific in hydrolyzing PAR in
vitro (6). Our data showed that SCO6735 removes ADP-ribo-
sylation from glutamate residues but does not reverse ADP-
ribosylated SCO5461. This is further evidence that the relevant
transferase(s) in Streptomyces are yet to be discovered.
SCO6735 and its orthologue BT1257 represent a new subgroup
of macrodomain proteins with a catalytic mechanism that is
different from any known macrodomain proteins.
Our results, in accordance with previous findings, suggest
the potential role of ADP-ribosylation in the regulation of
metabolism (antibiotic production) in Streptomyces, whereas
for the first time we have shown the possible involvement of
ADP-ribosylation in response to DNAdamage in Streptomyces.
Involvement of ADP-ribosylation in the repair of DNA damage
is well known and has been demonstrated in detail in
eukaryotes (44, 45). A few lines of evidence suggest that ADP-
ribosylation could also be involved in the DNAdamage response
in prokaryotes. In M. smegmatis, ADP-ribosyltransferase Arr
was up-regulated in response to various stresses, including
DNA damage (46). In D. radiodurans, PARG was up-regulated
uponUV-inducedDNAdamage, pointing out that degradation
of PAR could be more ancient than was initially considered
(39). Gene SCO6735 is under control of the RecANDp pro-
moter, and its expression is also up-regulated upon UV-in-
duced DNA damage. Nevertheless, using two different muta-
gens (UV light andMMS), we were not able to show significant
DNA damage-sensitive phenotype of the SCO6735-deficient
mutant. This may not be unexpected given that Streptomyces
possess multiple DNA repair systems that transcend bacterial
systems and are closer to those of lower eukaryotes (47, 48).
To conclude, we believe our findings will help to understand
ADP-ribosylation processes in Streptomyces (and bacteria in
general) and establish Streptomyces as an important model to
study bacterial ADP-ribosylation. Our data confirm that ADP-
ribosylation in Streptomyces could be evenmore widely utilized
than initially thought. For example, we uncovered possible
involvement of de-ADP-ribosylation process in the control of
antibiotic production and demonstrated a potential link
between ADP-ribosylation and the DNA damage response.
Experimental Procedures
Bacterial Strains, Culture Conditions, and Plasmids—S. coe-
licolor M145 strain, a derivative of the wild type strain A3(2)
lacking plasmids SCP1 and SCP2, was a generous gift fromProf.
M. Bibb and was used in this study as a wild type strain (49).
S. coelicolor strainswere grown at 30 °C in liquidmedium: com-
plete regeneration medium (50) and minimal medium (MM)
(49), and on solid media: mannitol soya flour, tryptic soy broth
(TSB) (Difco), nutrient agar (Difco), andMM. For actinorhodin
quantification and actinorhodin-related gene expression quan-
tification, spores of different S. coelicolor strains were inocu-
lated into complete regeneration medium and grown for 24 h.
The next day,mycelia werewashed inMMand continued incu-
bation in 50 ml of MM for 5 days at 30 °C and 250 rpm. Every
24 h, aliquots were taken for the further analyses.
E. coli XL1-Blue (New England Biolabs) was used for all
geneticmanipulations.E. coliBL21(DE3) (Stratagene) was used
for gene overexpression. Strains E. coli BW25113/pIJ790 and
ET12567/pUZ8002 and cosmid St5F2A (51) used for gene dis-
ruption by REDIRECT technology (34) were obtained from the
John Innes Centre (Norwich, UK). E. coli strains XL1-Blue and
BL21(DE3) were grown in LB liquid and solid medium at 37 °C,
whereas strain BW25113/pIJ790 at 30 °C until the loss of the plas-
mid with temperature sensitive origin of replication was needed.
Whennecessary, themediawere supplementedwithantibiotics to
the following concentrations: 100g/ml of ampicillin, 50g/ml of
apramycin, 25g/mlof chloramphenicol, 50g/mlof kanamycin,
25 g/ml of nalidixic acid, or 50 g/ml of hygromycin. All antibi-
otics were purchased from Sigma-Aldrich. Plasmid pET15b
(Novagen) was used for gene overexpression and Streptomyces-
specific integrative vector pMS82 (52) for complementation anal-
ysis (a generous gift from Prof. M. Smith).
Gene Cloning, Mutagenesis, Overexpression, and Protein
Purification—S. coelicolor genomic DNA was isolated as
described (49) and used for PCR amplification of the gene
encoding SCO6735 protein (NCBI, gene identifier 1102174)
with primers 6735F (CGGTGGCCATATGTCGGAGAT-
CAGCTATGTCC) and 6735R (GAGCCGCGGATCCCC-
TAGGCGGTGTCCCCG) that contain NdeI and BamHI
restriction sites. PCR product was digested with the same
restriction enzymes and cloned into pET15b. Specific point
mutation was introduced using this plasmid construct, mutant
primers 6735GEF (CCGCATAGGCTGCGAGCTGGCCG-
GCGGCAC) and 6735GER (GTGCCGCCGGCCAGCTCG-
CAGCCTATGCGG) and the asymmetric overlap extension
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PCR method for site-directed mutagenesis (53). The gene
encoding SCO5461 protein (NCBI, gene identifier 1100901)
was amplified using primers 5461F (GCCGCCCATATGC-
CGTCGGCTGCCCCCGCAAG) and 5461R (GAGCCAG-
GATCCCCGGTGTCAGTGCCAGGGC) and cloned into
pET15b. These primers were designed to skip the first 102
nucleotides (that correspond to the first 34 amino acids span-
ning the predicted transmembrane region). The resulting plas-
mid constructs were verified by sequencing and introduced
into E. coli BL21(DE3). Overexpression of the recombinant
SCO6735 gene in the 2-liter culture was induced with 0.1 mM
isopropyl -D-thiogalactopyranoside at A600 0.8 and contin-
ued at 16 °C overnight. Overexpression of the recombinant
SCO5461 gene in the 500-ml culture was induced with 0.8 mM
isopropyl -D-thiogalactopyranoside at A600 0.8 and contin-
ued at 30 °C for the next 3 h. Bacteria were harvested by cen-
trifugation, resuspended in buffer P (25 mM Tris-HCl, pH 7.5,
500 mM NaCl) containing 10 mM imidazole and 1 mg/ml
lysozyme and disrupted by sonication (5
 30 s). After remov-
ing cellular debris by centrifugation at 13,000 
 g for 30 min,
His-tagged recombinant proteins were purified by TALON
metal affinity chromatography (Clontech). TALON resin was
washed two times in buffer P containing 10 and 20 mM imidaz-
ole, whereas elution was performed with the same buffer con-
taining 200 mM imidazole. Purified proteins fractions were
pooled, desalted on PD10 columns (GEHealthcare), and stored
in buffer containing 25 mM Tris-HCl (pH 7.5), 50 mM NaCl, 1
mM EDTA, 1 mM DTT and 10% glycerol (v/v). PARP1 E988Q
mono-mutant was purified as described previously (7). Recom-
binant PARG was purified as described previously (54). pGEX-
4T1 GST-PARP10cd (amino acids 818–1025) was purified as
previously described (55) with slight modifications. Briefly,
after binding ofGST-taggedPARP10on glutathione-Sepharose
beads (GE Healthcare), the protein was extensively washed in
lysis buffer and equilibrated in PARP10 reaction buffer (50 mM
Tris-HCl, pH 7.5, 75 mM KCl, 4 mM MgCl2, 0.25 mM DTT).
Protein was kept on beads for the automodification reaction.
Gene Disruption and Complementation—Gene disruption
was done by replacing the entire coding region of SCO6735
gene with the apramycin resistance cassette using the
REDIRECT PCR targeting system (34). The SCO6735 disrupt-
ing cassette was generated by PCR using plasmid pIJ773 as a
template and specific primers 6735F (GGGGCCACTGT-
CAGTGGTGGCCCGTACGGTGGCGTCATGattccggggatc-
cgtcgacc) and 6735R (ACGAACGACGTGCACGAGCACT-
GAGCCGCGGACGGCCTAtgtaggctggagctgcttc), which match
the sequences adjacent to the SCO6735 coding region ending in
start/stop codons (capital letters) and right/left end of the disrup-
tion cassette (lowercase letters). PCR product was used to trans-
form E. coli strain BW25113/pIJ790 containing S. coelicolor cos-
mid St5F2A (carrying the SCO6735 gene). After recombination, a
strain with mutated cosmid was selected, cosmid was isolated,
introduced into E. coli ET12567/pUZ8002 to avoid methyl-
sensing restriction system, and transferred to S. coelicolor by con-
jugation. Exconjugants were screened for double cross-over
recombinants and verified by PCR (using primers T6735F:
GTGCTGCTGCTGCCCGTG and T6735R: CTGTTCCAGC-
CGTCGAAG), genomic Southern analysis, and qRT-PCR.
For the complementation analysis SCO6735 genewas ampli-
fied by PCR using S. coelicolor genomic DNA as a template and
specific primers with introduced SpeI and EcoRV restriction
sites (6735SpeI: TCGCGCACTAGTCCGGGCAGGAACGG-
CCGGCGCC and 6735EcoRV: GTGCACGATATCTGAG-
CCGCGGACGGCCTAGGC) and cloned into the site-specific
integrating vector pMS82 carrying attP-int locus derived from
the phage BT1 (52). Resulting plasmid construct (pMS82-
SCO6735) was verified by sequencing, introduced into S. coeli-
color 6735 strain by conjugation, and integrated into the
phage BT1 attB integration site via double cross-over.
Actinorhodin Quantification—Intracellular and extracellular
actinorhodin contents were quantified following the protocol
(56) with a single modification using 1 M NaOH instead of 1 M
KOH. Intracellular actinorhodin content was quantified from
1-ml culture pellet, whereas supernatant was used to quantify
the extracellular -actinorhodin. Bacteria were lysed with
NaOH, and actinorhodin was precipitated with HCl. Acti-
norhodin pellet was suspended in 1 M NaOH, and A640 was
measured. Concentrations were calculated according to the
Lambert-Beer’s law using molar extinction coefficient of the
pure actinorhodin in NaOH (640 25,320 liters mol1 cm1).
All quantifications were done on three independent biological
replicates of each of the genotypes.
RNA Isolation and Genes Expression Quantification by
qRT-PCR—The total RNA was isolated from 100-mg culture
pellets using the RNeasy mini kit (Qiagen) following the user
manual. Genomic DNA was degraded on column using DNase
I provided with the same kit. The quality of isolated RNA was
examined by agarose gel electrophoresis and spectrophoto-
metrically, whereas the absence ofDNAwas confirmed by PCR.
1 g of total RNA isolated from each sample was subjected to
reverse transcription using the high capacity cDNA reverse
transcription kit (Applied Biosystems). S. coelicolor 16S rRNA
housekeeping gene was used for normalization (57). The
SCO6735 gene was used as a negative control for the SCO6735
knock-out mutant. The following primers were used in qRT-
PCR analyses: SCO5085F, GTAATTTCGCATCCGCTGAAC;
SCO5085R, GGAGATTCCGATACGATTCCAG; SCO5087F,
GAAGGAGCTGTTCGGATTGAAG; SCO5087R, AGGTG-
AGCAGTTCCCAGAA; 16SF, GCGGCGGAGCATGTGG-
CTTA; 16SR, CACCTGTACACCGACCACAA; RT6735F,
GGCTGGGGCAAGGGCTTCGT; and RT6735R, GCGCCG-
AGACCGAAGTCGTT.
All primer pairs were tested a priori, and their efficiency was
measured as described (58) and used for the analyses of mean
normalized expression (58). Quantitative real time PCRs were
performed in 10-l volume using SYBRGreen PCRMasterMix
(Applied Biosystems), 900 nM primers (each), and 1.5 l of
cDNA. The thermal profile consisted of 10-min initial denatur-
ation at 95 °C followed by 40 cycles of 15 s at 95 °C and 1min at
60 °C. Each RNA sample was quantified two times in indepen-
dent experiments. Amplifications were done using the ABI
PRISM Sequence Analyzer 7300 (Applied Biosystems). Quan-
tification results were examined using SDS7300 software ver-
sion 1.4 (Applied Biosystems). Statistical analyses were done
using R version 3.2.1. Mean normalized expression (MNE) of
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the genes whose deregulation was tested by qRT-PCR was cal-
culated using the formula as described (58),
MNE 	 102
RCTR
GCTG
(Eq. 1)
where  is the efficiency of the primer pair amplifying either the
reference (i.e. housekeeping) gene (R) or the gene tested for
the deregulation (G), and [overbar]C[/overbar]T is themean value
of thresholdcycle inqRT-PCR.All quantificationsweredoneonat
least three independent biological replicates of each genotype.
UV and MMS Treatment—S. coelicolor spores suspended in
20% glycerol (v/v) were filtered through 1.2-m filters (Sarto-
rius) to obtain a single-spore suspension. For testing UV sensi-
tivity, 10ml of single-spore suspension in 20%glycerol (v/v)was
poured into a 9-cm glass Petri dish and irradiated with a con-
stant dose of UV light (50 J m2) six times using Philips 30 W
(254 nm) low pressure mercury lamp. The dose was measured
by VLX-3 W radiometer. The samples were taken after each
doze of irradiation, and the total dose was calculated as the sum
of all received doses. For testing MMS sensitivity, raising vol-
umes (from 0.1 to 1% (v/v)) of MMS stock solution (1.3 g/ml;
Sigma) were added to the aliquots of spores suspension and
incubated at 30 °C for 30 min. The reactions were terminated
by diluting the spores 1:10 in 0.16 M sodium thiosulfate (47).
After UV irradiation and MMS treatment, serial decimal dilu-
tions of each sample and each dose were spread on tryptic soy
broth plates and incubated at 30 °C for 24–48 h. Colony form-
ing units were counted, and survival rates were calculated. For
testing deregulation of the SCO6735 gene transcription upon
DNA damage, mycelium of S. coelicolor wild type strain was
irradiated with 200 J m2.
Phylogenetic Analysis—Protein sequences were obtained
from NCBI non-redundant database using human macrodo-
main proteins (MacroD1, TARG1, and ALC1) and a bacterial
type of PARG as a query (BLAST). Macrodomains were
selected from the retrieved protein sequences using SMART
database or manually in the case of PARG macrodomains and
aligned with the MUSCLE multiple alignment tool, using
default settings (59). Themultiple alignment was subjected to a
maximum likelihood (ML) analysis using MEGA6 (60). The
model forML analysis was selected with ProtTest3 (61) and the
Akaike information criterion (62), which indicated the Whel-
an_And_Goldman model (F G) (63). Bayesian MCMC anal-
ysis was performed in MrBayes version 3.1.2 (64). Bootstrap
tests were performed with 1000 replicates. For the structure-
based alignment, we used PRALINE (65).
Protein Crystallization and Structure Determination—For
crystallization, the protein SCO6735was concentrated up to 10
mg/ml in 25 mM Tris-HCl (pH 7.5), 50 mM NaCl, 1 mM EDTA,
1mMDTT, and 10% (v/v) glycerol. Initial conditions were iden-
tified utilizing sitting drop vapor diffusionmethod at 18 °Cwith
JCSG III crystallization suite (Qiagen). The best crystals were
obtained by hanging drop vapor diffusion method by equili-
brating a 1.0-l drop of protein mixture in a 1:1 ratio with
reservoir solution containing 0.1 M Tris-HCl (pH 7.0), 0.29 M
NaCl, and 1.0 M sodium citrate. Crystals grew in 5–14 days at
18 °C. Prior to flash cooling the crystals were soaked for few
seconds in the reservoir solution containing 20% ethylene gly-
col as additional cryoprotectant. The crystals contain onemac-
romolecule in the asymmetric unit corresponding toVm 9.85
Å3 Da1 and solvent content of 52.25%.
Single crystal x-ray data collection was done on Dectris Pila-
tus 2M area detector at Elettra Sincrotrone Trieste, Beamline
5.2R (Table 1). Data processing was performed with XDS (66),
and data scaling was performed with Aimless (67) within CCP4
(68) software suite. The structure was determined bymolecular
replacement with programMOLREP (69), using unknown pro-
tein from B. thetaiotaomicron as a model (PDB code 2FG1)
obtained by Phyre2 (70). Initial model was improved by several
cycles of refinement, using programs REFMAC (71, 72) and
Phenix (73). Data collection and refinement statistics are given
in Table 1. Final coordinates and structure factors have been
deposited in the Protein Data Bank (accession number 5E3B).
SCO6735 Activity Assay—To test the hydrolytic activity of
SCO6735, de-ADP-ribosylation assay was performed using
mono-ADP-ribosylated SCO5461N34 and human PARP1
E988Q mono-mutant (performing only mono-ADP-ribosylation
(7)) as substrates. Auto-ADP-ribosylation of SCO5461N34 sub-
strate was performed in the assay buffer (50 mM Tris-HCl, pH
7.5, 50 mM NaCl, 2 mM MgCl2) at room temperature using a
mixture of cold NAD (5 M) and [32P]NAD (2 Ci per reac-
tion) (PerkinElmer Life Sciences). After 30 min, the reactions
were split in two, and SCO6735 was added to one aliquot at 5
M concentration and incubated for additional 30 min. Auto-
TABLE 1
Data collection and refinement statistics
SCO6735
Data collection
Space group P 43212
Cell dimensions: a, b, c (Å) 103.82, 103.82, 33.25
Resolution (Å) 50-1.60 (1.64-1.60)
Rmergea 0.120 (1.18)
Rmeasb 0.128 (1.26)
I/
(I) 11.5 (1.8)
CC1/2 0.996 (0.670)
Completeness (%) 97.76 (89.47)
Redundancy 8.6
Refinement
Resolution (Å) 46.43-1.60
No. of reflections 22860
Rworkc/Rfreed 0.18/0.22 (0.26/0.35)
No. of atoms
Macromolecule 1167
Water 161
Ligand (1 ethylene glycol and 2 Na) 6
B-Factor
Macromolecule 19.31
Water 31.53
Ligand 22.53
RMSD
Bond lengths (Å) 0.023
Bond angles 2.252
Ramachandran statistics (%)
Most favored regions 97
Additional allowed regions 2
Outliers 1
a Rmerge hkliIi(hkl)	I(hkl)/hkliIi(hkl), where Ii(hkl) is the intensity of
a given reflection, and	I(hkl) is the mean intensity of symmetry-related
reflections.
b Rmeas hkln/(n 1)i1n Ihkl,i	Ihkl/hkljIhkl,j, where n is multiplicity.
Rmeas is redundancy-independent version of Rmerge.
c Rwork hklFobs Fcalc/hklFobs, where Fobs and Fcalc are the observed and
calculated structure factors, respectively.
d Rfree was calculated using 5% of the data set chosen at random that was excluded
from the refinement.
S. coelicolor Macrodomain Protein SCO6735
23184 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 291•NUMBER 44•OCTOBER 28, 2016
 at R
udjer Boskovic Institute on November 30, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
ADP-ribosylation of PARP1 E988Q mono-mutant was per-
formed as previously described (55, 74), using 0.5M of recom-
binant PARP1 E988Q. After 30 min, reaction were split and
treated or not with 1 M of SCO6735 or SCO6735 G128E
mutant. The reactions were stopped by adding SDS-PAGE
loading buffer and denatured at 80 °C for 5 min. The reaction
products were analyzed by SDS-PAGE and visualized by auto-
radiography. Quantification of residual radioactive signal on
PARP1 E988Q upon treatment with SCO6735 and SCO6735
G128E mutant was performed by ImageJ, normalizing the
intensity of autoradiography gel bands for the intensity of cor-
responding bands visualized on Coomassie staining.
Thin Layer Chromatography—To assess the release of
[32P]ADP-ribose upon treatment with SCO6735, we used recom-
binant GST-PARP10cd as a substrate. GST-PARP10cd was auto-
modified on beads in PARP10 reaction buffer in the presence of
coldNAD (50M)and[32P]NAD (2Ci/reaction) for15minat
37 °C with continuous agitation. After incubation, beads contain-
ing GST-PARP10cd were pelleted, washed five times in reaction
buffer, and split in two, and SCO6735 was added to one aliquot at
1 M concentration and incubated for additional 30 min. The
beads were pelleted again, and 1l of the liquid was phase-loaded
on the thin layer chromatography plate (TLC; Macherey-Nagel,
Polygram CEL 300 PEI/UV254). As [32P]ADP-ribose marker,
PARP1 (Trevigen) was automodified, passed three times through
G25 columns (GE Healthcare), and treated with recombinant
PARGas previously described (55, 74). The plates were developed
in0.15MLiCl and0.15Mformicacid.Driedplateswereexposedon
x-ray film (55, 74).
Mass Spectrometry Analysis—Auto-ADP-ribosylation of
SCO5461N34 protein (12.5 M) was performed in the assay
buffer (50 mM Tris-HCl, pH 7.5, 50 mMNaCl, 2 mMMgCl2) with
NAD (50 M) at room temperature for 30 min. Proteins were
digested with trypsin according to the FASP protocol (75) with a
10-kDa cut-off Vivacon 500 flat ultrafiltration filters (Sartorius
Stedim). The resulting peptides were analyzed by UHPLC-MS/MS
on an EASY-nLC 1000 liquid chromatography system (Thermo Sci-
entific)coupledonlinetoaQExactiveHForbitrapmassspectrometer
(ThermoScientific) essentially as describedbefore (2). Thedatawere
processed with MaxQuant (76) using parameters optimized for the
detection ofADP-ribosylated peptides (2).
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